APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sarcoma Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sarcoma Treatment Industry Growth and Trends Forecast to 2032

20 December 2025110 pages

Choose your research edition.

Industry ResearchSarcoma Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Sarcoma Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Sarcoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sarcoma Treatment Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Sarcoma Treatment Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Sarcoma Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Sarcoma Treatment market include Eisai Co., Ltd., Teva Pharmaceuticals, Johnson and Johnson, Novartis AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline and Fresenius Kabi AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sarcoma Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sarcoma Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sarcoma Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sarcoma Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Sarcoma Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sarcoma Treatment Market by Company

Eisai Co., Ltd.

Teva Pharmaceuticals

Johnson and Johnson

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

Pfizer Inc.

GlaxoSmithKline

Fresenius Kabi AG

Daiichi Sankyo Company Limited

Bayer AG

Bristol-Myers Squibb Company

F.Hoffmann-La Roche AG

Epizyme, Inc.

Baxter Healthcare Corporation

AgonOX, Inc.

Sarcoma Treatment Segment by Type

Stable Isotope

Radioisotope

Sarcoma Treatment Segment by Application

Others

Hospital

Laboratory

Sarcoma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sarcoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcoma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Sarcoma Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Sarcoma Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Sarcoma Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Sarcoma Treatment Market Share by Region (2021-2026) Table 4. Global Sarcoma Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Sarcoma Treatment Market Share by Region (2027-2032) Table 6. Global Sarcoma Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Sarcoma Treatment Market Size Share by Type (2021-2026) Table 9. Global Sarcoma Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Sarcoma Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Sarcoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Sarcoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Sarcoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Sarcoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Sarcoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Sarcoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Sarcoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Sarcoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Sarcoma Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Sarcoma Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Sarcoma Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Sarcoma Treatment Market Size Share by Application (2021-2026) Table 24. Global Sarcoma Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Sarcoma Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Sarcoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Sarcoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Sarcoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Sarcoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Sarcoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Sarcoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Sarcoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Sarcoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Sarcoma Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Sarcoma Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Sarcoma Treatment Industry Trends Table 37. Sarcoma Treatment Industry Drivers Table 38. Sarcoma Treatment Industry Opportunities and Challenges Table 39. Sarcoma Treatment Industry Restraints Table 40. Global Sarcoma Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Sarcoma Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Sarcoma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Sarcoma Treatment Key Company Headquarters & Area Served Table 44. Global Sarcoma Treatment Company, Product Type & Application Table 45. Global Sarcoma Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Sarcoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eisai Co., Ltd. Company Information Table 49. Eisai Co., Ltd. Business Overview Table 50. Eisai Co., Ltd. Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eisai Co., Ltd. Sarcoma Treatment Product Portfolio Table 52. Eisai Co., Ltd. Recent Development Table 53. Teva Pharmaceuticals Company Information Table 54. Teva Pharmaceuticals Business Overview Table 55. Teva Pharmaceuticals Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Pharmaceuticals Sarcoma Treatment Product Portfolio Table 57. Teva Pharmaceuticals Recent Development Table 58. Johnson and Johnson Company Information Table 59. Johnson and Johnson Business Overview Table 60. Johnson and Johnson Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson and Johnson Sarcoma Treatment Product Portfolio Table 62. Johnson and Johnson Recent Development Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis AG Sarcoma Treatment Product Portfolio Table 67. Novartis AG Recent Development Table 68. Merck & Co., Inc. Company Information Table 69. Merck & Co., Inc. Business Overview Table 70. Merck & Co., Inc. Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck & Co., Inc. Sarcoma Treatment Product Portfolio Table 72. Merck & Co., Inc. Recent Development Table 73. Eli Lilly and Company Company Information Table 74. Eli Lilly and Company Business Overview Table 75. Eli Lilly and Company Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eli Lilly and Company Sarcoma Treatment Product Portfolio Table 77. Eli Lilly and Company Recent Development Table 78. Pfizer Inc. Company Information Table 79. Pfizer Inc. Business Overview Table 80. Pfizer Inc. Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Inc. Sarcoma Treatment Product Portfolio Table 82. Pfizer Inc. Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Sarcoma Treatment Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Fresenius Kabi AG Company Information Table 89. Fresenius Kabi AG Business Overview Table 90. Fresenius Kabi AG Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Fresenius Kabi AG Sarcoma Treatment Product Portfolio Table 92. Fresenius Kabi AG Recent Development Table 93. Daiichi Sankyo Company Limited Company Information Table 94. Daiichi Sankyo Company Limited Business Overview Table 95. Daiichi Sankyo Company Limited Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Daiichi Sankyo Company Limited Sarcoma Treatment Product Portfolio Table 97. Daiichi Sankyo Company Limited Recent Development Table 98. Bayer AG Company Information Table 99. Bayer AG Business Overview Table 100. Bayer AG Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bayer AG Sarcoma Treatment Product Portfolio Table 102. Bayer AG Recent Development Table 103. Bristol-Myers Squibb Company Company Information Table 104. Bristol-Myers Squibb Company Business Overview Table 105. Bristol-Myers Squibb Company Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Company Sarcoma Treatment Product Portfolio Table 107. Bristol-Myers Squibb Company Recent Development Table 108. F.Hoffmann-La Roche AG Company Information Table 109. F.Hoffmann-La Roche AG Business Overview Table 110. F.Hoffmann-La Roche AG Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. F.Hoffmann-La Roche AG Sarcoma Treatment Product Portfolio Table 112. F.Hoffmann-La Roche AG Recent Development Table 113. Epizyme, Inc. Company Information Table 114. Epizyme, Inc. Business Overview Table 115. Epizyme, Inc. Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Epizyme, Inc. Sarcoma Treatment Product Portfolio Table 117. Epizyme, Inc. Recent Development Table 118. Baxter Healthcare Corporation Company Information Table 119. Baxter Healthcare Corporation Business Overview Table 120. Baxter Healthcare Corporation Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Baxter Healthcare Corporation Sarcoma Treatment Product Portfolio Table 122. Baxter Healthcare Corporation Recent Development Table 123. AgonOX, Inc. Company Information Table 124. AgonOX, Inc. Business Overview Table 125. AgonOX, Inc. Sarcoma Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AgonOX, Inc. Sarcoma Treatment Product Portfolio Table 127. AgonOX, Inc. Recent Development Table 128. North America Sarcoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Sarcoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Sarcoma Treatment Market Share by Country (2021-2026) Table 131. North America Sarcoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Sarcoma Treatment Market Share Forecast by Country (2027-2032) Table 133. Europe Sarcoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Sarcoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Sarcoma Treatment Market Share by Country (2021-2026) Table 136. Europe Sarcoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Sarcoma Treatment Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Sarcoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Sarcoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Sarcoma Treatment Market Share by Country (2021-2026) Table 141. Asia-Pacific Sarcoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Sarcoma Treatment Market Share Forecast by Country (2027-2032) Table 143. Latin America Sarcoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Sarcoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Sarcoma Treatment Market Share by Country (2021-2026) Table 146. Latin America Sarcoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Sarcoma Treatment Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Sarcoma Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Sarcoma Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Sarcoma Treatment Market Share by Country (2021-2026) Table 151. Middle East & Africa Sarcoma Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Sarcoma Treatment Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Sarcoma Treatment Product Image Figure 3. Global Sarcoma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Sarcoma Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Sarcoma Treatment Market Share by Region (2021-2032) Figure 7. North America Sarcoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Sarcoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Sarcoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Sarcoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Sarcoma Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Stable Isotope Image Figure 13. Global Stable Isotope Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Radioisotope Image Figure 15. Global Radioisotope Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Sarcoma Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Sarcoma Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Sarcoma Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Sarcoma Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Sarcoma Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Sarcoma Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Sarcoma Treatment Market Size Share by Type (2021-2032) Figure 23. Others Image Figure 24. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Laboratory Image Figure 28. Global Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Sarcoma Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sarcoma Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Sarcoma Treatment Market Size Share by Application (2021-2032) Figure 32. Europe Sarcoma Treatment Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Sarcoma Treatment Market Size Share by Application (2021-2032) Figure 34. Latin America Sarcoma Treatment Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Sarcoma Treatment Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Sarcoma Treatment Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Sarcoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Sarcoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Sarcoma Treatment Market Share by Country (2021-2032) Figure 41. Europe Sarcoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Sarcoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sarcoma Treatment Market Share by Country (2021-2032) Figure 44. Asia-Pacific Sarcoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Sarcoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Sarcoma Treatment Market Share by Country (2021-2032) Figure 47. Latin America Sarcoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Sarcoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Sarcoma Treatment Market Share by Country (2021-2032) Figure 50. Middle East & Africa Sarcoma Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Sarcoma Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Sarcoma Treatment Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Others
  • Hospital
  • Laboratory
Companies covered
  • Eisai Co., Ltd.
  • Teva Pharmaceuticals
  • Johnson and Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • GlaxoSmithKline
  • Fresenius Kabi AG
  • Daiichi Sankyo Company Limited
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F.Hoffmann-La Roche AG
  • Epizyme, Inc.
  • Baxter Healthcare Corporation
  • AgonOX, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Sarcoma Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Sarcoma Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Sarcoma Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Sarcoma Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Sarcoma Treatment Market Size (2021-2032)
  8. 1.5.1 North America Sarcoma Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Sarcoma Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Sarcoma Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Sarcoma Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Sarcoma Treatment Market Size Growth Rate (2021-2032)
2 Sarcoma Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Stable Isotope
  3. 2.1.2 Radioisotope
  4. 2.2 Global Sarcoma Treatment Market Size by Type
  5. 2.2.1 Global Sarcoma Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Sarcoma Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Sarcoma Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Sarcoma Treatment Market Size by Regions
  9. 2.3.1 North America Sarcoma Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Sarcoma Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Sarcoma Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Sarcoma Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Sarcoma Treatment Market Size Breakdown by Type (2021-2026)
3 Sarcoma Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Others
  3. 3.1.2 Hospital
  4. 3.1.3 Laboratory
  5. 3.2 Global Sarcoma Treatment Market Size by Application
  6. 3.2.1 Global Sarcoma Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Sarcoma Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Sarcoma Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Sarcoma Treatment Market Size by Regions
  10. 3.3.1 North America Sarcoma Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Sarcoma Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Sarcoma Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Sarcoma Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Sarcoma Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Sarcoma Treatment Industry Trends
  2. 4.2 Sarcoma Treatment Industry Drivers
  3. 4.3 Sarcoma Treatment Industry Opportunities and Challenges
  4. 4.4 Sarcoma Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Sarcoma Treatment Revenue (2021-2026)
  2. 5.2 Global Sarcoma Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Sarcoma Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Sarcoma Treatment Company, Product Type & Application
  5. 5.5 Global Sarcoma Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Sarcoma Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Sarcoma Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Sarcoma Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eisai Co., Ltd.
  2. 6.1.1 Eisai Co., Ltd. Company Information
  3. 6.1.2 Eisai Co., Ltd. Business Overview
  4. 6.1.3 Eisai Co., Ltd. Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Co., Ltd. Sarcoma Treatment Product Portfolio
  6. 6.1.5 Eisai Co., Ltd. Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Sarcoma Treatment Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Johnson and Johnson
  14. 6.3.1 Johnson and Johnson Company Information
  15. 6.3.2 Johnson and Johnson Business Overview
  16. 6.3.3 Johnson and Johnson Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson and Johnson Sarcoma Treatment Product Portfolio
  18. 6.3.5 Johnson and Johnson Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG Sarcoma Treatment Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
  25. 6.5 Merck & Co., Inc.
  26. 6.5.1 Merck & Co., Inc. Company Information
  27. 6.5.2 Merck & Co., Inc. Business Overview
  28. 6.5.3 Merck & Co., Inc. Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co., Inc. Sarcoma Treatment Product Portfolio
  30. 6.5.5 Merck & Co., Inc. Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Company Sarcoma Treatment Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 Pfizer Inc.
  38. 6.7.1 Pfizer Inc. Company Information
  39. 6.7.2 Pfizer Inc. Business Overview
  40. 6.7.3 Pfizer Inc. Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc. Sarcoma Treatment Product Portfolio
  42. 6.7.5 Pfizer Inc. Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Sarcoma Treatment Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Fresenius Kabi AG
  50. 6.9.1 Fresenius Kabi AG Company Information
  51. 6.9.2 Fresenius Kabi AG Business Overview
  52. 6.9.3 Fresenius Kabi AG Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Fresenius Kabi AG Sarcoma Treatment Product Portfolio
  54. 6.9.5 Fresenius Kabi AG Recent Developments
  55. 6.10 Daiichi Sankyo Company Limited
  56. 6.10.1 Daiichi Sankyo Company Limited Company Information
  57. 6.10.2 Daiichi Sankyo Company Limited Business Overview
  58. 6.10.3 Daiichi Sankyo Company Limited Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Daiichi Sankyo Company Limited Sarcoma Treatment Product Portfolio
  60. 6.10.5 Daiichi Sankyo Company Limited Recent Developments
  61. 6.11 Bayer AG
  62. 6.11.1 Bayer AG Company Information
  63. 6.11.2 Bayer AG Business Overview
  64. 6.11.3 Bayer AG Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bayer AG Sarcoma Treatment Product Portfolio
  66. 6.11.5 Bayer AG Recent Developments
  67. 6.12 Bristol-Myers Squibb Company
  68. 6.12.1 Bristol-Myers Squibb Company Company Information
  69. 6.12.2 Bristol-Myers Squibb Company Business Overview
  70. 6.12.3 Bristol-Myers Squibb Company Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb Company Sarcoma Treatment Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 6.13 F.Hoffmann-La Roche AG
  74. 6.13.1 F.Hoffmann-La Roche AG Company Information
  75. 6.13.2 F.Hoffmann-La Roche AG Business Overview
  76. 6.13.3 F.Hoffmann-La Roche AG Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 F.Hoffmann-La Roche AG Sarcoma Treatment Product Portfolio
  78. 6.13.5 F.Hoffmann-La Roche AG Recent Developments
  79. 6.14 Epizyme, Inc.
  80. 6.14.1 Epizyme, Inc. Company Information
  81. 6.14.2 Epizyme, Inc. Business Overview
  82. 6.14.3 Epizyme, Inc. Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Epizyme, Inc. Sarcoma Treatment Product Portfolio
  84. 6.14.5 Epizyme, Inc. Recent Developments
  85. 6.15 Baxter Healthcare Corporation
  86. 6.15.1 Baxter Healthcare Corporation Company Information
  87. 6.15.2 Baxter Healthcare Corporation Business Overview
  88. 6.15.3 Baxter Healthcare Corporation Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Baxter Healthcare Corporation Sarcoma Treatment Product Portfolio
  90. 6.15.5 Baxter Healthcare Corporation Recent Developments
  91. 6.16 AgonOX, Inc.
  92. 6.16.1 AgonOX, Inc. Company Information
  93. 6.16.2 AgonOX, Inc. Business Overview
  94. 6.16.3 AgonOX, Inc. Sarcoma Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AgonOX, Inc. Sarcoma Treatment Product Portfolio
  96. 6.16.5 AgonOX, Inc. Recent Developments
7 North America
  1. 7.1 North America Sarcoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Sarcoma Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Sarcoma Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Sarcoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Sarcoma Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Sarcoma Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Sarcoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Sarcoma Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Sarcoma Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Sarcoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Sarcoma Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Sarcoma Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Sarcoma Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Sarcoma Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Sarcoma Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst